Employee Benefit Plans (Tables)

9 Months Ended

Mar. 31, 2021

Share Based Compensation [Abstract]

Common Stock Reserved for Future Issuance

The Company had the following reserved shares of common stock for future issuance as of the dates noted (in thousands):

	March 31, 2021		June 30, 2020
2013 Equity Incentive Plan shares available for grant		6,518		13,118
Employee stock options and awards outstanding		11,327		10,396
2014 Employee Stock Purchase Plan		4,414		7,364
Total shares reserved for issuance		22,259		30,878

Schedule of Recognized Share-based Compensation Expense

Share-based compensation expense recognized in the condensed consolidated financial statements by line item caption is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	March 31, 2021		March 31, 2020		March 31, 2021		March 31, 2020
Cost of product revenues	$	297	$	280	$	869	$	932
Cost of service and subscription revenues		412		368		1,223		1,220
Research and development		2,414		2,518		7,380		8,213
Sales and marketing		3,150		1,338		9,036		8,568
General and administrative		2,925		2,639		9,087		7,523
Integration costs		—		—		—		479
Total share-based compensation expense	$	9,198	$	7,143	$	27,595	$	26,935

Summary of Stock Option Activity

The following table summarizes stock option activity for the nine months ended March 31, 2021 (in thousands, except per share and contractual term):

	Number of Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Options outstanding at June 30, 2020		2,922		$	4.95		3.09	$	1,688
Granted		—			—
Exercised		(415	)		3.44
Cancelled		(655	)		5.39
Options outstanding at March 31, 2021		1,852		$	5.14		3.55	$	6,687
Vested and expected to vest at March 31, 2021		1,852		$	5.14		3.55	$	6,687
Exercisable at March 31, 2021		903		$	3.69		2.21	$	4,577

Summary of Stock Award Activity

The following table summarizes stock award activity for the nine months ended March 31, 2021 (in thousands, except grant date fair value):

	Number of Shares			Weighted- Average Grant Date Fair Value		Aggregate Fair Market Value
Non-vested stock awards outstanding at June 30, 2020		7,474		$	6.83
Granted		6,015			4.87
Released		(3,047	)		7.16
Cancelled		(967	)		8.13
Non-vested stock awards outstanding at March 31, 2021		9,475		$	5.36	$	82,907
Vested and expected to vest at March 31, 2021		9,032		$	5.29	$	78,993

Schedule of Awards Performance Thresholds and Shares Expected to Vest (TSR PSUs)

The MSU award represents the right to receive a target number of shares of common stock up to 150% of the original grant. The MSUs vest based on the Company’s TSR relative to the TSR of the Index over performance periods from August 15, 2020 through August 15, 2023, subject to the grantees’ continued service through the certification of performance.

Level	Relative TSR	Shares Vested
Below Threshold	TSR is less than the Index by more than 37.5 percentage points	0%
Threshold	TSR is less than the Index by 37.5 percentage points	25%
Target	TSR equals the Index	100%
Maximum	TSR is greater than the Index by 25 percentage points or more	150%

Schedule of Fair Value Assumptions for Employee Stock Purchase Plan Awards

The following assumptions were used to determine the grant-date fair values of the ESPP shares during the following periods:

	Employee Stock Purchase Plan						Employee Stock Purchase Plan
	Three Months Ended						Nine Months Ended
	March 31, 2021			March 31, 2020			March 31, 2021			March 31, 2020
Expected life	0.5 years			0.5 years			0.5 years			0.5 years
Risk-free interest rate		0.05	%		1.56	%		0.09	%		1.71	%
Volatility		55	%		43	%		95	%		43	%
Dividend yield		—	%		—	%		—	%		—	%